Amgen

Open: 279.1 Close: 278.49 Change: -0.61

The best way to get information about Amgen Company Inc: Use an AI.

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, open, facility, manufacturing, central, Ohio, site, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen has opened a new biomanufacturing plant in Central Ohio, US. Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site.

Today's News

Amgen opens 300,000-square-foot facility in central ohio. amgen opens. facility in Central Ohio. Amgen announced that it has opened a new manufacturing site in central Ohio. Amgen is partnering with Columbus State Community College for an 18-month manufacturing apprenticeship at the site. Amgen opens new state-of-the-art facility in central Ohio, creating jobs and advancing biomanufacturing. Amgen Senior Engineer (Drug Substance Process Engineering) in Holly Springs, North Carolina. Responsible for planning, design, construction, operations and maintenance technical support. Amgen Inc. (AMGN) stock price, quote & news - stock analysis. Amgen inc. (amgn) stock. (AMgn) Stock Price, Quote & News - Stock Analysis. Amgen will present at the 34th Annual Oppenheimer Healthcare Life Sciences Conference at 12:00 p.m. February 6, 2024. Amgen has opened a new biomanufacturing plant in Central Ohio, US. It is the company s most advanced manufacturing facility to date. Amgen is an Equal Opportunity Employer. Amgen, Chevron share losses lead Dows 110-point fall - marketwatch.com. Shares of Amgen AMGN, -2.75% and Chevron CVX, -1.48% are contributing to the blue-chip gauges intraday. Amgen has invested $474 million in the New Albany facility. Amgen is partnering with Columbus State Community College for an 18-month manufacturing apprenticeship at the site. Amgen has been focused on protecting inventions in United States(US) with one publication in Q4 2023 The United States Patent Office dominates the patent filings and grants with nearly. Amgen stands in fifth position among its competitors in terms of grant share. Drug delivery devices related patents lead Amgen portfolio followed by packaging, pancreatic cancer, leukemia, and osteoporosis. Amgen opens state-of-the-art biomanufacturing site in central ohio. The New Albany plant represents an investment of half-billion dollars in American manufacturing. Amgen is hosting an inaugural 18-month manufacturing apprenticeship.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, open, facility, manufacturing, central, Ohio, site, and the most common words in the summary are: amgen, ohio, new, news, facility, company, drug, . One of the sentences in the summary was: Amgen has opened a new biomanufacturing plant in Central Ohio, US. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #ohio #new #news #facility #company #drug.